haploinsufficiency worsens DNA damage but not defective ciliogenesis in patient-derived iPSC-motoneurons
Serena Santangelo,Sabrina Invernizzi,Marta Nice Sorce,Valeria Casiraghi,Silvia Peverelli,Alberto Brusati,Claudia Colombrita,Nicola Ticozzi,Vincenzo Silani,Patrizia Bossolasco,Antonia Ratti
DOI: https://doi.org/10.1101/2024.03.07.582752
2024-03-12
Abstract:A hexanucleotide G C repeat expansion (HRE) in gene is the major cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), leading to both loss- and gain-of-function pathomechanisms. The wide clinical heterogeneity among patients suggests potential modifying genetic factors. Notably, mutations often co-occur with other variants in ALS/FTD-associated genes, such as , which encodes for a kinase involved in multiple pathways including DNA damage response and ciliogenesis. In this study, we generated induced pluripotent stem cells (iPSCs) and differentiated motoneurons (iPSC-MNs) derived from an ALS patient carrying both HRE and a loss-of-function mutation to study the effect of the haploinsufficiency on pathology. Double mutant / cells showed increased pathological RNA foci in iPSCs and higher DNA damage levels in iPSC-MNs compared to single mutant cells. In contrast, ciliogenesis was similarly impaired in both and iPSC-MNs showing shorter cilia. Altogether, our study supports the use of patient-derived iPSCs to functionally explore the contribution of genetic modifiers in -associated pathology.
Neuroscience
What problem does this paper attempt to address?